Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy

Figure 2

Schematic representation of mechanisms of action of antiplatelet agents. PAR-l: protease activated thrombin receptor-1. Adapted from [128].